- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02851654
Interest of Eye Movement Measurements in the Comprehension of Dry Eyes Symptoms (BOSO)
December 10, 2019 updated by: Fondation Ophtalmologique Adolphe de Rothschild
Interest of Eye Movement Measurements in the Comprehension of Dry Eyes Symptoms (BOSO)
Dry eye syndrome is a benign situation however its impact on patient's quality of live and on health system is not trivial.
One problem is the lack of correlation between patient's symptoms and physical sign observed on slit lamp examination.
Eye blinking is a parameter of increased interest in this pathology particularly its frequency.
To date no treatment of dry eye syndrome has a proven impact on eye blinking frequency.
However recording of blinks has mostly been performed on short duration (3 to 5 minutes) and the distribution of intervals between 2 blinks is not gaussian but exponential.
In this study, it is proposed to use modern eye-movement recorder to measure the blink frequency on longer duration (12 minutes) while reading on a screen computer and during a face-to-face interview before and after treatment of meibomian gland dysfunction responsible of moderate to severe dry eye syndrome.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
24
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Paris, France, 75019
- Fondation Ophtalmologique Adolphe de Rothschild (FOR)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with moderate to severe dry eye syndrome from meibomian gland dysfunction
Description
Inclusion Criteria:
- Moderate to severe dry eye syndrome (Ocular Surface Disease Index> 30) following a meibomian gland dysfunction
- Not yet properly treated for a meibomian gland dysfunction
Exclusion Criteria:
- History of other ophthalmological or neurological disease
- Pregnant or breastfeeding women
- Patient under 18 years old
- Patient under legal protection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Dry eye syndrome
Meibomian gland dysfunction responsible of moderate to severe dry eye syndrome
|
The infrared oculography provides binocular recordings and allows simultaneous measurement of horizontal and vertical eye movements.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
duration between 2 blinks
Time Frame: 2 months after treatment
|
Assessment by infrared oculography while the patient is reading on a computer screen and during a face-to-face interview
|
2 months after treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
November 5, 2014
Primary Completion (ACTUAL)
October 30, 2019
Study Completion (ACTUAL)
October 30, 2019
Study Registration Dates
First Submitted
July 28, 2016
First Submitted That Met QC Criteria
July 28, 2016
First Posted (ESTIMATE)
August 1, 2016
Study Record Updates
Last Update Posted (ACTUAL)
December 11, 2019
Last Update Submitted That Met QC Criteria
December 10, 2019
Last Verified
December 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CLL_2013-16
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dry Eye Syndromes
-
Southern College of OptometryNot yet recruitingEye Diseases | Dry Eye | Chronic Dry Eye
-
University of MiamiNot yet recruitingEye Diseases | Dry Eye | Eyes Dry ChronicUnited States
-
Singapore National Eye CentreThe Eye Hospital of Wenzhou Medical UniversityNot yet recruiting
-
The Hong Kong Polytechnic UniversityRecruitingDry Eye | Dry Eye Disease (DED)Hong Kong
-
Southern College of OptometryNot yet recruitingEye Diseases | Dry Eye | Dry Eye Syndromes | Dry Eyes Chronic
-
Southern College of OptometryRecruitingEye Diseases | Dry Eye | Eyes Dry ChronicUnited States
-
RudacureNot yet recruiting
-
Indiana UniversityRecruiting
-
Essilor InternationalNot yet recruiting
-
Vanda PharmaceuticalsRecruiting
Clinical Trials on Infrared oculography
-
Universitair Ziekenhuis BrusselNot yet recruitingMultiple Sclerosis | Internuclear Ophthalmoplegia
-
Alexander TarnutzerNot yet recruitingVertigo | Acute Vestibular Syndrome | Stroke Acute | Acute Unilateral Vestibulopathy (AUV)
-
Munich Municipal HospitalCompletedStroke | Vertigo | DizzinessGermany
-
Inje UniversityCompletedStrabismus | ExotropiaKorea, Republic of
-
Hospital de Clinicas de Porto AlegreUnknownNatural History of Oculomotor Neurophysiology in Ataxic and Pre-ataxic Carriers of SCA3/MJD (BIGPRO)Spinocerebellar Ataxia Type 3 | Machado-Joseph DiseaseBrazil
-
Association de Recherche Bibliographique pour les...Centre Hospitalier Universitaire de Nice; Centre Hospitalier Princesse GraceCompletedHealthy | Clinically Isolated Syndrome | Multiple Sclerosis (MS) | Radiologically Isolated Syndrome | Multiple Sclerosis (MS) Relapsing Remitting | Multiple Sclerosis (MS) Primary Progressive | Multiple Sclerosis (MS) Secondary ProgressiveMonaco
-
Inje UniversityUnknownStrabismus | Intermittent ExotropiaKorea, Republic of
-
Association de Recherche Bibliographique pour les...Centre Hospitalier Universitaire de Nice; Centre Hospitalier Princesse GraceRecruiting
-
Association de Recherche Bibliographique pour les...University of Cambridge; Centre Hospitalier Princesse Grace; Institut National...CompletedBrain Injuries | Sport Injury | Concussion, BrainMonaco